Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness: United States, 2022

Authors

Mark W Tenforde, Centers for Disease Control and Prevention
Jennie H Kwon, Washington University School of Medicine in St. Louis
et al.

Journal

Clinical infectious diseases

Publication Date

3-21-2023

Volume

76

Issue

6

First Page

1030

Last Page

1037

Document Type

Open Access Publication

DOI

10.1093/cid/ciac869

Rights and Permissions

Mark W Tenforde, Manish M Patel, Nathaniel M Lewis, Katherine Adams, Manjusha Gaglani, Jay S Steingrub, Nathan I Shapiro, Abhijit Duggal, Matthew E Prekker, Ithan D Peltan, David N Hager, Michelle N Gong, Matthew C Exline, Adit A Ginde, Nicholas M Mohr, Christopher Mallow, Emily T Martin, H Keipp Talbot, Kevin W Gibbs, Jennie H Kwon, James D Chappell, Natasha Halasa, Adam S Lauring, Christopher J Lindsell, Sydney A Swan, Kimberly W Hart, Kelsey N Womack, Adrienne Baughman, Carlos G Grijalva, Wesley H Self, for the Influenza and Other Viruses in the Acutely Ill (IVY) Network, Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022, Clinical Infectious Diseases, Volume 76, Issue 6, 15 March 2023, Pages 1030–1037, https://doi.org/10.1093/cid/ciac869. https://academic.oup.com/cid/article/76/6/1030/6795261?login=true. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Recommended Citation

Tenforde, Mark W; Kwon, Jennie H; and et al., "Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness: United States, 2022." Clinical infectious diseases. 76, 6. 1030 - 1037. (2023).
https://digitalcommons.wustl.edu/oa_4/1507

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.